XML 50 R14.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Accrued Expenses | 12 Months Ended
--- | ---
Dec. 31, 2023
Payables and Accruals [Abstract] |
Accrued Expenses | Accrued Expenses Accrued expenses consisted of the following (in thousands):
| December 31,
| 2023 |  | 2022
Clinical study patient costs incurred but not yet invoiced | $ | 439 |  |  | $ | 1,393 |
Accrued vacation, wages, bonuses, and related payroll taxes | 392 |  |  | 329 |
Accrued other | 60 |  |  | 2 |
Total | $ | 891 |  |  | $ | 1,724 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration